185 related articles for article (PubMed ID: 8137354)
1. The role of pharmacogenetics in chemotherapy: modulation of tumour response and host toxicity.
Boddy AV; Idle JR
Cancer Surv; 1993; 17():79-104. PubMed ID: 8137354
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacokinetics of anti-metabolites.
Peters GJ; Schornagel JH; Milano GA
Cancer Surv; 1993; 17():123-56. PubMed ID: 8137339
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics for individualized cancer chemotherapy.
Efferth T; Volm M
Pharmacol Ther; 2005 Aug; 107(2):155-76. PubMed ID: 15890408
[TBL] [Abstract][Full Text] [Related]
4. Interpreting disparate responses to cancer therapy: the role of human population genetics.
Maitland ML; DiRienzo A; Ratain MJ
J Clin Oncol; 2006 May; 24(14):2151-7. PubMed ID: 16682733
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics in biological perspective.
Kalow W
Pharmacol Rev; 1997 Dec; 49(4):369-79. PubMed ID: 9443163
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacogenetics of anticancer drugs].
de Chaisemartin L; Loriot MA
Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
[TBL] [Abstract][Full Text] [Related]
7. [Value and applications of pharmacogenetics in oncology and hematology].
Albin N; Massade L; Gouyette A
Bull Cancer; 1997 Jun; 84(6):643-51. PubMed ID: 9295869
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics in cancer treatment.
Nagasubramanian R; Innocenti F; Ratain MJ
Annu Rev Med; 2003; 54():437-52. PubMed ID: 12525681
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of anticancer drugs in non-Hodgkin lymphomas.
Loni L; Del Tacca M; Danesi R
Br J Cancer; 2001 Nov; 85(10):1425-31. PubMed ID: 11720423
[TBL] [Abstract][Full Text] [Related]
10. Using genetic variation to optimize cancer chemotherapy.
McLeod HL; Papageorgio C; Watters JW
Clin Adv Hematol Oncol; 2003 Feb; 1(2):107-11. PubMed ID: 16224389
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of osteoporosis: future perspectives.
Marini F; Brandi ML
Calcif Tissue Int; 2009 May; 84(5):337-47. PubMed ID: 19271099
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology and pharmacogenetics of chemotherapeutic agents.
Dawood S; Leyland-Jones B
Cancer Invest; 2009 Jun; 27(5):482-8. PubMed ID: 19479485
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the pharmacogenetics of cancer chemotherapy.
Watters JW; McLeod HL
Curr Opin Mol Ther; 2002 Dec; 4(6):565-71. PubMed ID: 12596358
[TBL] [Abstract][Full Text] [Related]
14. Current overview of pharmacogenetics.
McLeod HL
Clin Adv Hematol Oncol; 2004 Apr; 2(4):205-7. PubMed ID: 16163181
[No Abstract] [Full Text] [Related]
15. [Pharmacogenomic approaches for prevention of drug toxicity in cancer chemotherapy].
Hasegawa Y
Gan To Kagaku Ryoho; 2003 Mar; 30(3):325-33. PubMed ID: 12669388
[TBL] [Abstract][Full Text] [Related]
16. Somatic pharmacogenomics in cancer.
Ikediobi ON
Pharmacogenomics J; 2008 Oct; 8(5):305-14. PubMed ID: 18679398
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer.
Danesi R; de Braud F; Fogli S; de Pas TM; Di Paolo A; Curigliano G; Del Tacca M
Pharmacol Rev; 2003 Mar; 55(1):57-103. PubMed ID: 12615954
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic failure of antineoplastic agents. Extracellular and cellular causes].
Hofsli E
Tidsskr Nor Laegeforen; 1991 Jan; 111(1):37-40. PubMed ID: 2000585
[TBL] [Abstract][Full Text] [Related]
19. [Recent advances in pharmacogenomics in oncology].
Robert J; Bonnet J
Bull Cancer; 2004 Jan; 91(1):19-28. PubMed ID: 14975802
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics in cancer chemotherapy: balancing toxicity and response.
Donnelly JG
Ther Drug Monit; 2004 Apr; 26(2):231-5. PubMed ID: 15228171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
